References
Evans SE, Ost DE (2015) Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med 21(3):260–271
Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Crit Care Clin 17(3):531–570 vii-viii
Auberger J et al. (2012) Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 67(9):2268–2273
Garcia-Suarez J et al. (2011) Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses 54(4):318–324
Tuon FF, Costa SF (2008) Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 25(3):135–140
Nunes JM et al. (2013) Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother 57(1):382–389
Acknowledgments
Fischer, J., Hamacher, L., Hallek, M., Cornely, O.A., Kochanek, M. and Boell, B. treated the patient and wrote the manuscript. Fries, J. performed the section of the patient and the liver histology. We thank the patient and her family for allowing us to publish her case for education purposes.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
J.F. was funded by a clinical leave stipend from the German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Kerpener Str. 62, D-50,931 Cologne, Germany and by a starter grant from Köln-Fortune, Cologne, Germany.
Conflict of interest
J.F., L.H., J.F., M.H., M.K. and B.B. declare that they have no conflict of interest. OAC is supported by the German Federal Ministry of Research and Education, has received research grants from 3M, Actelion, Astellas, AstraZeneca, Basilea, Bayer, Celgene, Cubist/Optimer, Duke University (NIH UM1AI104681), Genzyme, Gilead, GSK, Leeds University, Merck/MSD, Miltenyi, NanoMR, Pfizer, Quintiles, Scynexis, Viropharma, is a consultant to Amplyx, Anacor, Astellas, Basilea, Cidara, Da Volterra, Daiichi Sankyo, F2G, Genentech/Roche, Gilead, Matinas, MedPace, Merck/MSD, Merck Serono, Pfizer, Sanofi Pasteur, Scynexis, Seres, Summit, Vical, Vifor and has received lecture honoraria from Astellas, Basilea, Gilead, Merck/MSD and Pfizer.
Additional information
J. Fischer and L. Hamacher equally contributed to this work.
Rights and permissions
About this article
Cite this article
Fischer, J., Hamacher, L., Fries, J. et al. Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL. Ann Hematol 95, 1569–1570 (2016). https://doi.org/10.1007/s00277-016-2726-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-016-2726-7